血管内皮増殖因子B、血管内皮細胞増殖因子B
- 関
- VEGF-B
WordNet
- cultivate by growing, often involving improvements by means of agricultural techniques; "The Bordeaux region produces great red wines"; "They produce good ham in Parma"; "We grow wheat here"; "We raise hogs here" (同)raise, farm, produce
- come to have or undergo a change of (physical features and attributes); "He grew a beard"; "The patient developed abdominal pains"; "I got funny spots all over my body"; "Well-developed breasts" (同)develop, produce, get, acquire
- become attached by or as if by the process of growth; "The tree trunks had grown together"
- become larger, greater, or bigger; expand or gain; "The problem grew too large for me"; "Her business grew fast"
- cause to grow or develop; "He grows vegetables in his backyard"
- increase in size by natural process; "Corn doesnt grow here"; "In these forests, mushrooms grow under the trees"; "her hair doesnt grow much anymore"
- (biology) the process of an individual organism growing organically; a purely biological unfolding of events involved in an organism changing gradually from a simple to a more complex level; "he proposed an indicator of osseous development in children" (同)growing, maturation, development, ontogeny, ontogenesis
- (pathology) an abnormal proliferation of tissue (as in a tumor)
- a progression from simpler to more complex forms; "the growth of culture"
- something grown or growing; "a growth of hair"
- vegetation that has grown; "a growth of trees"; "the only growth was some salt grass"
- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
- the 2nd letter of the Roman alphabet (同)b
- the blood group whose red cells carry the B antigen (同)type_B, group B
PrepTutorEJDIC
- 『成長する』,育つ,〈植物が〉生える,茂る / (類・量・程などにおいて)『増大する』,大きくなる / 『しだいになる』 / …‘を'成長させる,大きくする,育てる / …から生じる(起こる)
- 〈U〉(…の)『成長』,発育;『発達』,発展《+『of』+『名』》 / 〈U〉(数・量,重要性・力などの)『増加』,増大,拡張《+『of』+『名』》 / 〈U〉《修飾語[句]を伴って》栽培,生産,…産 / 〈C〉成育した物,(草,木,髪,ひげなどの)生えたもの / 〈C〉腫瘍(しゅよう)
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/08/25 08:45:04」(JST)
[Wiki en表示]
Vascular endothelial growth factor B |
PDB rendering based on 2c7w. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
2C7W, 2VWE, 2XAC
|
|
|
Identifiers |
Symbols |
VEGFB ; VEGFL; VRF |
External IDs |
OMIM: 601398 MGI: 106199 HomoloGene: 87131 GeneCards: VEGFB Gene |
Gene ontology |
Molecular function |
• protein binding
• growth factor activity
• heparin binding
• chemoattractant activity
• protein homodimerization activity
• vascular endothelial growth factor receptor 1 binding
• protein heterodimerization activity
|
Cellular component |
• extracellular region
• extracellular space
• membrane
• platelet alpha granule lumen
|
Biological process |
• angiogenesis
• positive regulation of endothelial cell proliferation
• platelet degranulation
• protein O-linked glycosylation
• blood coagulation
• negative regulation of gene expression
• platelet activation
• positive regulation of vascular endothelial growth factor receptor signaling pathway
• positive regulation of vascular wound healing
• response to drug
• negative regulation of apoptotic process
• positive regulation of vascular permeability
• negative regulation of neuron apoptotic process
• vascular endothelial growth factor receptor signaling pathway
• positive regulation of peptidyl-tyrosine phosphorylation
• positive chemotaxis
• induction of positive chemotaxis
• positive regulation of cell division
• positive regulation of protein kinase B signaling
• cardiac muscle contraction
• positive regulation of mast cell chemotaxis
• coronary vasculature development
• positive regulation of ERK1 and ERK2 cascade
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
7423 |
22340 |
|
Ensembl |
ENSG00000173511 |
ENSMUSG00000024962 |
|
UniProt |
P49765 |
P49766 |
|
RefSeq (mRNA) |
NM_001243733 |
NM_001185164 |
|
RefSeq (protein) |
NP_001230662 |
NP_001172093 |
|
Location (UCSC) |
Chr 11:
64 – 64.01 Mb |
Chr 19:
6.98 – 6.99 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Vascular endothelial growth factor B also known as VEGF-B is a protein that, in humans, is encoded by the VEGF-B gene.[1] VEGF-B is a growth factor that belongs to the vascular endothelial growth factor family, of which VEGF-A is the best-known member.
Contents
- 1 Function
- 2 Interactions
- 3 References
- 4 Further reading
Function
In contrast to VEGF-A, VEGF-B plays a less pronounced role in the vascular system: Whereas VEGF-A is important for the formation of blood vessels, such as during development or in pathological conditions, VEGF-B seems to play a role only in the maintenance of newly formed blood vessels during pathological conditions.[2] VEGF-B plays also an important role on several types of neurons. It is important for the protection of neurons in the retina[3] and the cerebral cortex during stroke [4] and of motoneurons during motor neuron diseases such as amyotrophic lateral sclerosis.[5]
VEGF-B exerts its effects via the FLT1 receptor.[6]
VEGF-B has also been found to control endothelial uptake and transport of fatty acids in heart and skeletal muscle.[7][8]
Interactions
Vascular endothelial growth factor B has been shown to interact with FLT1.[9][10]
References
- ^ "Entrez Gene: VEGFB vascular endothelial growth factor B".
- ^ Zhang F, Tang Z, Hou X, Lennartsson J, Li Y, Koch AW, Scotney P, Lee C, Arjunan P, Dong L, Kumar A, Rissanen TT, Wang B, Nagai N, Fons P, Fariss R, Zhang Y, Wawrousek E, Tansey G, Raber J, Fong GH, Ding H, Greenberg DA, Becker KG, Herbert JM, Nash A, Yla-Herttuala S, Cao Y, Watts RJ, Li X (April 2009). "VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis". Proc. Natl. Acad. Sci. U.S.A. 106 (15): 6152–7. doi:10.1073/pnas.0813061106. PMC 2669337. PMID 19369214.
- ^ Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P, Lennartsson J, Zhu C, Qu Y, Fang C, Hua J, Matsuo O, Fong GH, Ding H, Cao Y, Becker KG, Nash A, Heldin CH, Li X (March 2008). "VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats". J. Clin. Invest. 118 (3): 913–23. doi:10.1172/JCI33673. PMC 2230661. PMID 18259607.
- ^ Sun Y, Jin K, Childs JT, Xie L, Mao XO, Greenberg DA (October 2004). "Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice". J. Cereb. Blood Flow Metab. 24 (10): 1146–52. doi:10.1097/01.wcb.0000134477.38980.38. PMID 15529014.
- ^ Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van Den Bosch L, Meert T, D'Hooge R, Sendtner M, Robberecht W, Carmeliet P (October 2008). "Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration". J. Neurosci. 28 (42): 10451–9. doi:10.1523/JNEUROSCI.1092-08.2008. PMID 18923022.
- ^ Yamazaki Y, Morita T (November 2006). "Molecular and functional diversity of vascular endothelial growth factors". Mol. Divers. 10 (4): 515–27. doi:10.1007/s11030-006-9027-3. PMID 16972015.
- ^ Muoio DM (July 2010). "Metabolism and vascular fatty acid transport". N. Engl. J. Med. 363 (3): 291–3. doi:10.1056/NEJMcibr1005397. PMID 20647206.
- ^ Hagberg CE, Mehlem A, Falkevall A, Muhl L, Fam BC, Ortsäter H, Scotney P, Nyqvist D, Samén E, Lu L, Stone-Elander S, Proietto J, Andrikopoulos S, Sjöholm A, Nash A, Eriksson U (October 2012). "Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes". Nature 490 (7420): 426–30. doi:10.1038/nature11464. PMID 23023133.
- ^ Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U (September 1998). "Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells". Proc. Natl. Acad. Sci. U.S.A. 95 (20): 11709–14. doi:10.1073/pnas.95.20.11709. PMC 21705. PMID 9751730.
- ^ Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K (July 1999). "Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1". J. Biol. Chem. 274 (30): 21217–22. doi:10.1074/jbc.274.30.21217. PMID 10409677.
Further reading
- Poesen K, Lambrechts D et al. (2008). "Novel Role for Vascular Endothelial Growth Factor (VEGF)Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration". J. Neurosci. 28 (42): 10451–9. doi:10.1523/JNEUROSCI.1092-08.2008. PMID 18923022.
- Joukov V, Kaipainen A, Jeltsch M, et al. (1997). "Vascular endothelial growth factors VEGF-B and VEGF-C.". J. Cell. Physiol. 173 (2): 211–5. doi:10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H. PMID 9365524.
- Olofsson B, Pajusola K, Kaipainen A, et al. (1996). "Vascular endothelial growth factor B, a novel growth factor for endothelial cells.". Proc. Natl. Acad. Sci. U.S.A. 93 (6): 2576–81. doi:10.1073/pnas.93.6.2576. PMC 39839. PMID 8637916.
- Olofsson B, Pajusola K, von Euler G, et al. (1996). "Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform.". J. Biol. Chem. 271 (32): 19310–7. doi:10.1074/jbc.271.32.19310. PMID 8702615.
- Grimmond S, Lagercrantz J, Drinkwater C, et al. (1996). "Cloning and characterization of a novel human gene related to vascular endothelial growth factor.". Genome Res. 6 (2): 124–31. doi:10.1101/gr.6.2.124. PMID 8919691.
- Olofsson B, Korpelainen E, Pepper MS, et al. (1998). "Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.". Proc. Natl. Acad. Sci. U.S.A. 95 (20): 11709–14. doi:10.1073/pnas.95.20.11709. PMC 21705. PMID 9751730.
- Makinen T, Olofsson B, Karpanen T, et al. (1999). "Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1.". J. Biol. Chem. 274 (30): 21217–22. doi:10.1074/jbc.274.30.21217. PMID 10409677.
- Ikuta T, Ariga H, Matsumoto K (2001). "Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation.". Genes Cells 5 (11): 913–927. doi:10.1046/j.1365-2443.2000.00376.x. PMID 11122379.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Qi JH, Ebrahem Q, Moore N, et al. (2003). "A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.". Nat. Med. 9 (4): 407–15. doi:10.1038/nm846. PMID 12652295.
- Trompezinski S, Berthier-Vergnes O, Denis A, et al. (2004). "Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts.". Exp. Dermatol. 13 (2): 98–105. doi:10.1111/j.0906-6705.2004.00137.x. PMID 15009103.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Timoshenko AV, Chakraborty C, Wagner GF, Lala PK (2006). "COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.". Br. J. Cancer 94 (8): 1154–63. doi:10.1038/sj.bjc.6603067. PMC 2361247. PMID 16570043.
- Iyer S, Scotney PD, Nash AD, Ravi Acharya K (2006). "Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.". J. Mol. Biol. 359 (1): 76–85. doi:10.1016/j.jmb.2006.03.002. PMID 16616187.
- Yamada E, Yamazaki K, Takano K, et al. (2007). "Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors.". Thyroid 16 (6): 545–54. doi:10.1089/thy.2006.16.545. PMID 16839256.
- de Paulis A, Prevete N, Fiorentino I, et al. (2007). "Expression and functions of the vascular endothelial growth factors and their receptors in human basophils.". J. Immunol. 177 (10): 7322–31. doi:10.4049/jimmunol.177.10.7322. PMID 17082651.
PDB gallery
|
|
|
2c7w: CRYSTAL STRUCTURE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR-B: IDENTIFICATION OF AMINO ACIDS IMPORTANT FOR ANGIOGENINC ACTIVITY
|
|
|
|
Growth factors
|
|
Fibroblast |
FGF receptor ligands: |
- FGF1/FGF2/FGF5
- FGF3/FGF4/FGF6
|
|
KGF |
- FGF7/FGF10/FGF22
- FGF8/FGF17/FGF18
- FGF9/FGF16/FGF20
|
|
FGF homologous factors: |
|
|
hormone-like: |
|
|
|
EGF-like domain |
|
|
TGFβ pathway |
|
|
Insulin-like |
|
|
Platelet-derived |
|
|
Vascular endothelial |
- VEGF-A
- VEGF-B
- VEGF-C
- VEGF-D
- PGF
|
|
Other |
|
|
B trdu: iter (nrpl/grfl/cytl/horl), csrc (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd; path (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease.
- Falk T, Yue X, Zhang S, McCourt AD, Yee BJ, Gonzalez RT, Sherman SJ.SourceDepartment of Neurology, College of Medicine, The University of Arizona, Tucson, AZ 85724, United States. tfalk@u.arizona.edu
- Neuroscience letters.Neurosci Lett.2011 May 27;496(1):43-7. Epub 2011 Apr 12.
- Developing novel neuroprotective strategies for the treatment of Parkinson's disease (PD) is of great importance. We have previously shown that vascular endothelial growth factor-B (VEGF-B) is up-regulated in an in vitro model of PD using the neurotoxin rotenone. Addition of exogenous VEGF-B(167) wa
- PMID 21507340
- The endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: role of VEGF-B.
- Xu M, Jin Y, Song Q, Wu J, Philbrick MJ, Cully BL, An X, Guo L, Gao F, Li J.SourceDepartment of Physiology, Fourth Military Medical University, Xi'an, China.
- Cardiovascular research.Cardiovasc Res.2011 May 1;90(2):325-34. Epub 2010 Dec 17.
- AIMS: Related transcription enhancer factor-1 (RTEF-1) has previously been demonstrated to play an important role in both endothelial cells and cardiomyocytes. However, the function of RTEF-1 in the communication between these two adjacent cell types has not been elucidated.METHODS AND RESULTS: We h
- PMID 21169295
Japanese Journal
- 肺高血圧症動物モデルからの知見 (特集 肺高血圧症 : 初期診断・治療・管理のすべて)
- Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model
- CLINICAL INVESTIGATION : Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment
- Japanese journal of ophthalmology : the official international journal of the Japanese Ophthalmological Society 60(2), 86-94, 2016-03
- NAID 40020763448
Related Links
- Vascular endothelial growth factor-B (VEGF-B) protects against experimental stroke, but the effect of stroke on VEGF-B expression is uncertain. ... Background Vascular endothelial growth factor-B (VEGF-B) protects against ...
- 1. Nature. 2010 Apr 8;464(7290):917-21. doi: 10.1038/nature08945. Epub 2010 Mar 14. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van ...
★リンクテーブル★
[★]
- 英
- vascular endothelial growth factor B、VEGF-B
- 関
- 血管内皮細胞増殖因子B
[★]
- 英
- vascular endothelial growth factor B
- 関
- 血管内皮増殖因子B
[★]
- 関
- vascular endothelial growth factor B
[★]
- Mg2+存在下でC3, B, Dが反応してC3bBbとなり、これがC3転換酵素(C3bBb)あるいはC5転換酵素(C3bBb3b)を形成する。これらはP(properdin)と結合して活性化し、それぞれC3、C5を活性化する
[★]
- (過去: grew-過去分詞: grown)
- 関
- extend、growth、outgrow、outgrowth、stretch
[★]
- 関
- angio、blood vessel、fibrovascular bundle、vascular bundle、vasculogenic、vein、vessel
[★]
- 関
- actual、actually、in fact、in practice、indeed、practically
[★]
- 関
- element、elementary、factorial、parameter